ECHA Weekly - 11 July 2018

Call for evidence: restriction of perfluorohexane-1-sulphonic acid, its salts and related substances

Norway is preparing an Annex XV restriction dossier concerning perfluorohexane-1-sulphonic acid, its salts and related substances (EC -, CAS -) and is requesting interested parties to submit any information they have to help with the preparation of the dossier.

The deadline for comments is 22 August 2018 (23:59 Helsinki time).

Current calls for comments and evidence

Note on substance identification and scope of restriction on microplastics published

ECHA is currently assessing the need for a restriction on intentional uses of microplastic particles. As an outcome of the stakeholder workshop on microplastics held in May, ECHA has now published a note outlining the identification of microplastics and the steps the Agency will take to understand the remaining unresolved issues. The note also elaborates on the relationship between substance identification and the potential scope of possible restriction. ECHA aims to conclude its investigation by January 2019.

Note | Event page | Hot topics page

Authorisation granted for uses of 1,2-dichloroethane (EDC)

The European Commission has granted authorisation for uses of 1,2-dichloroethane (EDC) (EC 203-458-1; CAS 107-06-2) by H&R Ölwerke Schindler GmbH and H&R Chemisch-Pharmazeutische Spezialitäten GmbH.

Read the summary

New proposals and intentions to harmonise classification and labelling

Three new intentions to harmonise the classification and labelling have been received for:

• carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro- 4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate (EC -, CAS 128639-02-1);
• clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine (EC 277-728-2, CAS 74115-24-5); and
• N-(2-nitrophenyl)phosphoric triamide (EC 477-690-9, CAS 874819-71-3).

Two new proposals to harmonise the classification and labelling have been submitted for:

• triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (EC 603-543-7, CAS 131983-72-7); and
• diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide (EC 617-446-2, CAS 83164-33-4).

Two intentions have been withdrawn, for:

• empenthrin (ISO); 1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (EC 687-638-9, CAS 918500-11-5); and
• iprodione (ISO); 3-(3,5-dichlorophenyl)-N-isopropyl-2,4-dioxoimidazolidine-1-carboxamide (EC 253-178-9, CAS 36734-19-7).

Registry of intentions